![]() |
市場調查報告書
商品編碼
1880645
單絲可吸收縫線市場規模、佔有率、成長及全球產業分析:依類型、應用和地區劃分的洞察與預測(2024-2032 年)Monofilament Absorbable Sutures Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032 |
||||||
受全球外科手術數量不斷增加以及先進傷口閉合解決方案的快速普及的推動,全球單絲可吸收縫合線市場正經歷強勁增長。預計該市場規模將在 2024 年達到 5.593 億美元,2025 年達到 5.841 億美元,到 2032 年達到 9.327 億美元,預測期內複合年增長率 (CAGR) 為 6.9%。這些縫合線由合成或天然材料的單根細絲製成,由於其可在體內自然溶解,無需取出,因此在內視鏡手術和微創手術中至關重要。 2024年,北美憑藉先進的醫療基礎設施和龐大的手術量,佔了32.33%的市場佔有率,佔主導地位。
單絲可吸收縫線廣泛應用於一般外科、骨科、心血管外科和婦科。其光滑的單股結構可減少組織摩擦,最大限度地降低炎症,從而改善癒合效果。全球對感染控制意識的提升以及微創手術的普及,進一步推動了這類縫線的需求。
市場推動因素
推動市場擴張的關鍵因素是全球手術數量的快速成長,涵蓋骨科、心臟病學、婦產科和整形外科等領域。根據加拿大健康資訊研究所 (CIHI) 的數據,全球剖腹產率持續上升,預計2023年將達到33.4%。此外,美國國家生物技術資訊中心 (NCBI) 報告稱,每年約有 40 萬例冠狀動脈旁路移植術。這些趨勢顯著增加了單絲可吸收縫合線的消耗量,而單絲可吸收縫合線對於內部傷口縫合至關重要。
此外,全球人口老化使得慢性疾病患者更容易接受手術治療,例如血管成形術、關節置換術和器官移植。這一因素進一步推動了對可吸收縫合線的長期需求,尤其是那些旨在減少術後不適和併發症風險的縫合線。
市場限制因子
儘管預計市場將成長,但由於手術縫合器、組織黏合劑和止血劑等替代傷口縫合技術的日益普及,市場面臨挑戰。這些方法具有應用速度更快、感染風險更低和美觀性更佳等優勢。根據 Suture Planet(2025 年 2 月)的報告,與縫線相比,縫合器可加快傷口閉合速度並減少組織損傷,從而限制了單絲可吸收縫線在某些外科領域的應用。
新興市場對價格高度敏感,且缺乏對縫線相關最佳實踐的了解,也阻礙了縫合器的廣泛應用。
市場機會
隨著亞洲、中東和非洲等發展中國家醫療基礎設施的不斷完善,預計這些國家將迎來強勁的成長機會。新建醫院、專科醫療中心和外科培訓設施的投資增加,顯著推動了對縫線的需求。例如,沙迦的 Al Qasimi 醫院於 2024 年安裝了先進的心臟模擬技術,印度的 Inamdar 綜合醫院於 2025 年開設了一家專業的牙科和臉部外科診所。隨著醫療服務可近性的提高,預計手術數量將會增加,從而促使單絲可吸收縫線的消耗量增加。
市場挑戰
術後併發症(例如感染、過敏反應和肉芽腫形成)仍然是一個挑戰。這些問題可能促使外科醫生選擇不可吸收縫線或其他縫合系統。此外,FDA 和 EMA 等監管機構實施的嚴格監管框架增加了研發時間和成本,尤其對於中小型製造商而言。
主要趨勢
重塑市場的關鍵趨勢是無結可吸收縫線的日益普及,尤其是在微創心血管、骨科和腹腔鏡手術中。這些縫線可減少手術部位感染,並消除與結相關的併發症。臨床研究,例如 2022 年發表在 "英國外科雜誌" 上的一份報告,顯示與傳統縫線相比,使用無結倒刺縫線可顯著降低手術部位感染率。此外,抗菌塗層和生物工程單絲縫合線正在迅速普及。
The global monofilament absorbable sutures market is witnessing strong growth as surgical volumes rise worldwide and advanced wound closure solutions gain rapid acceptance. The market was valued at USD 559.3 million in 2024, is projected to increase to USD 584.1 million in 2025, and is anticipated to reach USD 932.7 million by 2032, expanding at a CAGR of 6.9% over the forecast period. These sutures, made from a single filament of synthetic or natural materials, dissolve naturally in the body and eliminate the need for removal, making them essential in internal and minimally invasive surgeries. In 2024, North America held a dominant market share of 32.33%, supported by advanced healthcare infrastructure and high surgical procedure volume.
Monofilament absorbable sutures are widely used in general surgery, orthopedics, cardiovascular procedures, and gynecology. Their smooth, single-strand design reduces tissue drag and minimizes inflammation, improving healing outcomes. Increasing global awareness around infection control and the shift towards minimally invasive procedures have further strengthened demand for these sutures.
Market Drivers
A key driver for market expansion is the rapid rise in global surgical procedures, spanning orthopedics, cardiology, obstetrics, and cosmetic surgery. Cesarean section rates continue escalating worldwide-Canada recorded 33.4% of deliveries by C-section in 2023, according to CIHI. Furthermore, the National Center for Biotechnology Information (NCBI) reports that around 400,000 coronary bypass surgeries are conducted annually. Such trends significantly increase consumption of monofilament absorbable sutures, which are crucial for internal wound closure.
Additionally, the aging global population is more susceptible to chronic diseases requiring surgical intervention, such as angioplasty, joint replacement, and organ transplantation. This factor further fuels long-term demand for absorbable sutures, especially those designed to reduce post-surgical discomfort and complication risks.
Market Restraints
Despite growth, the market faces challenges due to the rising adoption of alternative wound closure technologies, including surgical staplers, tissue adhesives, and hemostats. These methods offer advantages such as faster application, lower infection risks, and improved aesthetic outcomes. As per Suture Planet (February 2025), staplers provide faster closure and reduced tissue damage compared to sutures, which limits the use of monofilament absorbable sutures in specific surgical disciplines.
Price sensitivity in emerging markets, coupled with limited awareness of suture-related best practices, also hinders widespread adoption.
Market Opportunities
Developing countries across Asia, the Middle East, and Africa represent strong growth opportunities due to expanding healthcare infrastructure. Increasing investments in new hospitals, specialty centers, and surgical training facilities significantly boost suture demand. For instance, Al Qassimi Hospital in Sharjah adopted advanced cardiac simulation technology in 2024, while Inamdar Multispecialty Hospital in India opened a dedicated Dental & Face Surgery Clinic in 2025. As healthcare access improves, surgical volumes will rise, resulting in higher consumption of monofilament absorbable sutures.
Market Challenges
Post-surgical complications such as infection, hypersensitivity reactions, and granuloma formation continue to pose challenges. These issues may push surgeons toward non-absorbable or alternative closure systems. Moreover, stringent regulatory frameworks enforced by agencies like the FDA and EMA increase development time and cost, particularly for smaller manufacturers.
Key Trends
A major trend reshaping the market is the growing adoption of knotless absorbable sutures, especially for minimally invasive cardiovascular, orthopedic, and laparoscopic surgeries. These sutures reduce surgical site infections and eliminate knot-related complications. Clinical studies, such as the 2022 British Journal of Surgery report, highlight significant reductions in SSI rates when using knotless barbed sutures compared to conventional types. Additionally, antimicrobial-coated and bioengineered monofilament sutures are rapidly gaining traction.
Conclusion
With the market growing from USD 559.3 million in 2024 to USD 932.7 million by 2032, the monofilament absorbable sutures industry is set for sustained expansion driven by escalating surgical procedures, technological advancements, and broader healthcare access. While regulatory hurdles and competing technologies pose challenges, rising preference for minimally invasive solutions and improvements in suture design ensure strong long-term growth.
Segmentation By Type, Application, End-user, and Region
By Type * Natural
By Application * Gynecology
By End-user * Hospitals & ASCs
By Region * North America (By Type, by Application, by End-user, and by Country)
U.S.
Canada
Germany
U.K.
France
Italy
Spain
Scandinavia
Rest of Europe
China
Japan
India
Australia
Southeast Asia
Rest of Asia Pacific
Brazil
Mexico
Rest of Latin America
GCC
South Africa
Rest of the Middle East & Africa